Pfizer vaccine production on the rise as pandemic hits one-year mark

By the fourth quarter of this year, Pfizer and BioNTech will reach a 3 billion dose a year production run rate, and should be able to produce that much next year, Pfizer Chief Executive said

Pfizer Inc and German partner BioNTech SE will exceed their original global production target for Covid-19 vaccines by as much as 20% this year, as they ramp up production a year into the global pandemic, Pfizer Chief Executive Albert Bourla said on Thursday.
 

The companies also released real-world data from Israel earlier on Thursday suggesting their vaccine was 94% effective in preventing asymptomatic infections, suggesting it could significantly reduce virus transmission.
 

"These are stunning numbers that are giving us a clear indication that liberation is coming," Bourla said in an interview on the one-year anniversary of the World Health Organization